Literature DB >> 2790603

Mortality rates among patients with end-stage renal disease in Canada, 1981-86.

J Silins1, L Fortier, Y Mao, G Posen, A M Ugnat, A Brancker, L Gaudette, D Wigle.   

Abstract

We assessed the mortality rates by age, sex, race, blood type, primary diagnosis, treatment and transplantation history of 8432 patients in Canada for whom end-stage renal disease (ESRD) was diagnosed between 1981 and 1986. Significant differences in the probability of dying were found between those with and without diabetes mellitus, between those who had received a renal transplant and those who had not, between white and nonwhite patients and between various age groups. The mortality rates of the ESRD patients were at least three times higher than those of the general Canadian population. Primary diagnosis and treatment were significantly associated with the risk of dying among the ESRD patients. For those who had received a transplant, the length of time spent waiting for a transplant was positively associated with the risk of death from ESRD. Patients who had received peritoneal dialysis before transplantation had a higher risk of death than those who had received either hemodialysis (risk ratio 1.3) or transplantation (risk ratio 3.2) as the first treatment. No significant differences were found in the cause of death between those who had received peritoneal dialysis and those who had received hemodialysis. Almost half of the deaths among women without diabetes who had received a transplant were due to infection.

Entities:  

Mesh:

Year:  1989        PMID: 2790603      PMCID: PMC1452765     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  8 in total

1.  Prognostic factors, models and related statistical problems in the survival of endstage renal disease patients on hemodialysis.

Authors:  A J Umen; C T Le
Journal:  Stat Med       Date:  1986 Nov-Dec       Impact factor: 2.373

2.  Racial differences in the incidence of treatment for end-stage renal disease.

Authors:  S G Rostand; K A Kirk; E A Rutsky; B A Pate
Journal:  N Engl J Med       Date:  1982-05-27       Impact factor: 91.245

3.  Survival analysis of patients undergoing dialysis.

Authors:  P J Held; M V Pauly; L Diamond
Journal:  JAMA       Date:  1987-02-06       Impact factor: 56.272

4.  Results of 12 years' treatment of chronic renal failure by dialysis and transplantation.

Authors:  J D Price; K M Ashby; C E Reeve
Journal:  Can Med Assoc J       Date:  1978-02-04       Impact factor: 8.262

5.  Survival of patients treated for end-stage renal disease by dialysis and transplantation.

Authors:  M R Higgins; M Grace; J B Dossetor
Journal:  Can Med Assoc J       Date:  1977-10-22       Impact factor: 8.262

6.  The recent U.S. experience in the treatment of end-stage renal disease by dialysis and transplantation.

Authors:  H Krakauer; J S Grauman; M R McMullan; C C Creede
Journal:  N Engl J Med       Date:  1983-06-30       Impact factor: 91.245

7.  Results of treatment in patients with end-stage renal disease: a multivariate analysis of risk factors and survival in 341 successive patients.

Authors:  G Garcia-Garcia; J A Deddens; R D'Achiardi-Rey; M R First; S J Samuels; S Kant; V E Pollak
Journal:  Am J Kidney Dis       Date:  1985-01       Impact factor: 8.860

8.  Survival rates of 2,728 patients with end-stage renal disease.

Authors:  W L Hellerstedt; W J Johnson; N Ascher; C M Kjellstrand; R Knutson; F L Shapiro; S Sterioff
Journal:  Mayo Clin Proc       Date:  1984-11       Impact factor: 7.616

  8 in total
  3 in total

1.  Differences in the treatment of male and female patients with end-stage renal disease.

Authors:  C Florakas; R Wilson; E Toffelmire; M Godwin; R Morton
Journal:  CMAJ       Date:  1994-11-01       Impact factor: 8.262

2.  Excess mortality among patients on dialysis: Comparison with the general population in Korea.

Authors:  Hyungyun Choi; Myounghee Kim; Hyunwook Kim; Jung Pyo Lee; Jeonghwan Lee; Jung Tak Park; Kyoung Hoon Kim; Hyeong Sik Ahn; Hoo Jae Hann; Dong-Ryeol Ryu
Journal:  Kidney Res Clin Pract       Date:  2014-05-28

3.  ABO blood type is associated with renal outcomes in patients with IgA nephropathy.

Authors:  Meng Yang; Jingyuan Xie; Yan Ouyang; Xiaoyan Zhang; Manman Shi; Xiao Li; Zhaohui Wang; Pingyan Shen; Hong Ren; Wen Zhang; Weiming Wang; Nan Chen
Journal:  Oncotarget       Date:  2017-09-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.